Drug profile · INN
nanoparticle albumin-bound paclitaxel
NAB-PACLITAXEL JUNO
nanoparticle albumin-bound paclitaxel (NAB-PACLITAXEL JUNO) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — nanoparticle albumin-bound paclitaxel
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
nanoparticle albumin-bound paclitaxel (NAB-PACLITAXEL JUNO) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN nanoparticle albumin-bound paclitaxel
Brand NAB-PACLITAXEL JUNO
Mechanism Tubulin inhibitor
Target Tubulin
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nanoparticle albumin-bound paclitaxel?
nanoparticle albumin-bound paclitaxel (NAB-PACLITAXEL JUNO) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for nanoparticle albumin-bound paclitaxel?
NAB-PACLITAXEL JUNO is a marketed brand name for nanoparticle albumin-bound paclitaxel. Check FDA Drugs@FDA for the current US label holder and prescribing information.